MedShape, Inc.

MedShape, Inc. develops innovative solutions for foot and ankle surgical procedures, focusing on advanced bioengineering technologies to enhance patient outcomes during recovery. Founded by Douglas Pacaccio and Reed Bartz, MedShape, Inc. specializes in surgical products for foot and ankle conditions.

The company is headquartered in Atlanta, US. In July 2017, CONMED acquired MedShape's ExoShape ACL product line, marking a significant pivot in its business strategy. MedShape has raised a total of USD 0. 70 mn through multiple funding rounds, with the most recent round occurring on July 5, 2017, where the company was the investment target and received USD 0.

70 mn. MedShape, Inc. offers a diverse portfolio of advanced surgical products for foot and ankle solutions, including the STAR® Total Ankle implant and the DynaNail® TTC Fusion System. Their range includes plating, screw, staple, and biologics solutions that address various foot and ankle conditions, including deformities and fractures, and are utilized by healthcare practitioners across major markets, including the United States and Canada.

MedShape operates on a business-to-business model, generating revenue through direct sales of surgical products to medical institutions and healthcare providers. Their pricing structures are based on product specifications, including proprietary solutions like the STAR® Ankle and DynaNail® system. The company enhances its revenue streams through educational programs aimed at increasing product usage and familiarity among surgical teams. MedShape plans to expand its product offerings with new designs and launches focused on enhancing surgical outcomes.

The company is targeting expansion into new geographical markets, specifically in international regions by the end of 2024. Recent funding will be allocated to support these expansion initiatives and the development of new products to enhance its existing portfolio.